Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger
- PMID: 24443565
- PMCID: PMC3945346
- DOI: 10.1074/jbc.M113.527655
Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger
Abstract
The three deleted in liver cancer genes (DLC1-3) encode Rho-specific GTPase-activating proteins (RhoGAPs). Their expression is frequently silenced in a variety of cancers. The RhoGAP activity, which is required for full DLC-dependent tumor suppressor activity, can be inhibited by the Src homology 3 (SH3) domain of a Ras-specific GAP (p120RasGAP). Here, we comprehensively investigated the molecular mechanism underlying cross-talk between two distinct regulators of small GTP-binding proteins using structural and biochemical methods. We demonstrate that only the SH3 domain of p120 selectively inhibits the RhoGAP activity of all three DLC isoforms as compared with a large set of other representative SH3 or RhoGAP proteins. Structural and mutational analyses provide new insights into a putative interaction mode of the p120 SH3 domain with the DLC1 RhoGAP domain that is atypical and does not follow the classical PXXP-directed interaction. Hence, p120 associates with the DLC1 RhoGAP domain by targeting the catalytic arginine finger and thus by competitively and very potently inhibiting RhoGAP activity. The novel findings of this study shed light on the molecular mechanisms underlying the DLC inhibitory effects of p120 and suggest a functional cross-talk between Ras and Rho proteins at the level of regulatory proteins.
Keywords: Arginine Finger; DLC1; Deleted in Liver Cancer; GTPase; Kinetics; Molecular Modeling; RhoGAP; SH3 Domains; Structural Biology; p120RasGAP.
Figures
Similar articles
-
SH3 domain regulation of RhoGAP activity: Crosstalk between p120RasGAP and DLC1 RhoGAP.Nat Commun. 2022 Aug 15;13(1):4788. doi: 10.1038/s41467-022-32541-4. Nat Commun. 2022. PMID: 35970859 Free PMC article.
-
p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.Oncogene. 2009 Mar 19;28(11):1401-9. doi: 10.1038/onc.2008.498. Epub 2009 Jan 19. Oncogene. 2009. PMID: 19151751 Free PMC article.
-
Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.Proc Natl Acad Sci U S A. 2007 May 22;104(21):9012-7. doi: 10.1073/pnas.0703033104. Epub 2007 May 15. Proc Natl Acad Sci U S A. 2007. PMID: 17517630 Free PMC article.
-
p120-Ras GTPase activating protein (RasGAP): a multi-interacting protein in downstream signaling.Biochimie. 2009 Mar;91(3):320-8. doi: 10.1016/j.biochi.2008.10.010. Epub 2008 Oct 30. Biochimie. 2009. PMID: 19022332 Review.
-
Regulation of deleted in liver cancer 1 tumor suppressor by protein-protein interactions and phosphorylation.Int J Cancer. 2014 Jul 15;135(2):264-9. doi: 10.1002/ijc.28505. Epub 2013 Oct 17. Int J Cancer. 2014. PMID: 24114040 Review.
Cited by
-
The potential therapeutic roles of Rho GTPases in substance dependence.Front Mol Neurosci. 2023 Mar 30;16:1125277. doi: 10.3389/fnmol.2023.1125277. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37063367 Free PMC article.
-
Functional Classification and Interaction Selectivity Landscape of the Human SH3 Domain Superfamily.Cells. 2024 Jan 20;13(2):195. doi: 10.3390/cells13020195. Cells. 2024. PMID: 38275820 Free PMC article.
-
The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction.Genes (Basel). 2021 May 27;12(6):819. doi: 10.3390/genes12060819. Genes (Basel). 2021. PMID: 34071831 Free PMC article. Review.
-
Controlling the Revolving and Rotating Motion Direction of Asymmetric Hexameric Nanomotor by Arginine Finger and Channel Chirality.ACS Nano. 2019 Jun 25;13(6):6207-6223. doi: 10.1021/acsnano.8b08849. Epub 2019 May 28. ACS Nano. 2019. PMID: 31067030 Free PMC article. Review.
-
Deciphering the Molecular and Functional Basis of RHOGAP Family Proteins: A SYSTEMATIC APPROACH TOWARD SELECTIVE INACTIVATION OF RHO FAMILY PROTEINS.J Biol Chem. 2016 Sep 23;291(39):20353-71. doi: 10.1074/jbc.M116.736967. Epub 2016 Aug 1. J Biol Chem. 2016. PMID: 27481945 Free PMC article.
References
-
- Aznar S., Lacal J. C. (2001) Searching new targets for anticancer drug design: the families of Ras and Rho GTPases and their effectors. Prog. Nucleic Acid Res. Mol. Biol. 67, 193–234 - PubMed
-
- Fritz G., Just I., Kaina B. (1999) Rho GTPases are over-expressed in human tumors. Int. J. Cancer 81, 682–687 - PubMed
-
- Pruitt K., Der C. J. (2001) Ras and Rho regulation of the cell cycle and oncogenesis. Cancer Lett. 171, 1–10 - PubMed
-
- Sahai E., Marshall C. J. (2002) RHO-GTPases and cancer. Nat. Rev. Cancer 2, 133–142 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous